Boaz Weinstein’s Aspire Biopharma Warrant ASBPW Stock Holding History

Boaz Weinstein’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9K	Hold	983,603	–	–	﹤0.01%	347
2026 Q1	$17.9K	Hold	983,603	–	–	﹤0.01%	336
2025 Q4	$19.3K	Hold	983,603	–	–	﹤0.01%	298
2025 Q3	$29.4K	Hold	983,603	–	–	﹤0.01%	272
2025 Q2	$44.2K	Hold	983,603	–	–	﹤0.01%	247
2025 Q1	$71.8K	Hold	983,603	–	–	﹤0.01%	167
2024 Q4	$40.6K	Hold	983,603	–	–	﹤0.01%	193
2024 Q3	$41.6K	Hold	983,603	–	–	﹤0.01%	220
2024 Q2	$36.8K	Hold	983,603	–	–	﹤0.01%	254
2024 Q1	$29.6K	Hold	983,603	–	–	﹤0.01%	282
2023 Q4	$63.9K	Hold	983,603	–	–	﹤0.01%	312
2023 Q3	$49.9K	Hold	983,603	–	–	﹤0.01%	381
2023 Q2	$49.3K	Hold	983,603	–	–	﹤0.01%	414
2023 Q1	$44.3K	Hold	983,603	–	–	﹤0.01%	558
2022 Q4	$40K	Hold	983,603	–	–	﹤0.01%	674
2022 Q3	$143K	Hold	983,603	–	–	﹤0.01%	741
2022 Q2	$157K	Buy	+983,603	New	+$214K	﹤0.01%	785

Other funds holding ASBPW

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Boaz Weinstein's ASBPW Position: Q2 2026 in Review

Boaz Weinstein held its Aspire Biopharma Warrant (ASBPW) position steady in Q2 2026 at 983,603 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Boaz Weinstein first reported a position in ASBPW in Q2 2022 and has held it in 17 quarters since. The position peaked at $157K in Q2 2022. 27 funds tracked by Wall St. Rank hold ASBPW as of Q2 2026.

Boaz Weinstein held 983,603 shares of Aspire Biopharma Warrant worth $22.9K as of Q2 2026.
Boaz Weinstein left its Aspire Biopharma Warrant share count unchanged in Q2 2026.
Aspire Biopharma Warrant made up ﹤0.01% of Boaz Weinstein's portfolio in Q2 2026, its #347 holding.
Boaz Weinstein first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 17 quarters since.
Boaz Weinstein's Aspire Biopharma Warrant position peaked at $157K in Q2 2022.
27 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.